ELVN Enliven Therapeutics Inc

held 6 mo · 2 quarters on record · no longer held ELVN across all managers

Position over time

Period	Shares	% of portfolio	Activity	Value
Q3 2025	947,405	0.49%	Add ×2.0	$19M
Q2 2025	463,000	0.24%	NEW	$9M

Search